Browse by category

The rapid rise of GLP-1 medications such as semaglutide and tirzepatide has transformed obesity treatment. Still, experts say medications alone are not enough to address one of the US’ most pressing chronic diseases. A commentary published in Gastroenterology, "Revisiting POWER in the GLP-1 Age," updates the landmark POWER (Practice Guide on Obesity and Weight Management, Education, and Resources) framework first published in 2017. The figure provides a comprehensive, multidi

Adults with obesity and diabetes face higher health care utilisation costs with GLP-1s treatment compared with Bariatric metabolic surgery (BMS), excluding intervention costs, largely reflecting differences in early clinical trajectories, according to a study by researchers from Israel. These findings suggest that, among patients eligible for both interventions, BMS may confer combined clinical and economic advantages over long-term follow-up. The study was designed to compar

Both Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) are cost-effective compared with no surgery for adolescents with severe obesity, according to a study by researchers from the Northwestern University Feinberg School of Medicine. Dr John B Rode from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues examined the ten-year cost effectiveness of metabolic and bariatric surgery for adolescents with severe obesity using published resul

Shimadzu Medical Systems USA has launched the FLUOROspeed X1 edition ST, patient side conventional RF table system with a 665lb static patient weight capacity (500lb all motion weight capacity), for both bariatric and routine daily fluoroscopic and radiographic exams. According to the company, the X1 offers a cost-effective balance of functionality to support a wide range of general RF applications, such as chest, abdomen, or extremities along with Upper GI's, modified swallo

The first commercial EndoZip Automated Suturing System for Endoscopic Sleeve Gastroplasty (ESG) cases have been performed in France. The cases were performed at the Institute of Image-Guided Surgery (IHU Strasbourg) in Strasbourg, France, under the leadership of Professor Silvana Perretta, Chief of Foregut Surgery and Advanced Gastrointestinal Endoscopy. This milestone represents another important step in Nitinotes' European commercial expansion following recent introductions

The American College of Physicians (ACP) has issued a new living clinical guideline to help physicians choose medications with lifestyle modifications to manage overweight and obesity in adults. The guideline, ‘Pharmacologic Treatments with Lifestyle Modifications in Nonpregnant Adults with Overweight or Obesity in Outpatient Settings: A Living Clinical Guideline from the American College of Physicians’, was is published in Annals of Internal Medicine. More than half (59%) of

Researchers from the Norwegian University of Science and Technology (NTNU) have reported that patients who have bariatric surgery absorbs alcohol much more rapidly and patients need to know this when they choose the kind of surgery they will have. "Bariatric surgery can come with a price. Patients have a significantly higher risk of developing alcohol problems than if they did not undergo surgery," said Magnus Strømmen, a researcher at the Center for Obesity Research at St. O

GT Metabolic Solutions has received CE certification (CE Mark) under the EU Medical Device Regulation (EU MDR) that enables commercialisation of the GT Metabolic Magnet System across the European Economic Area (EEA). GT Metabolic achieved successful review and certification of the GT Metabolic Magnet System for side-to-side enteroenterostomy (40mm, 50mm Magnets; throughout the small bowel) and gastroenterostomy (60mm, 70mm Magnets; stomach to small bowel), the first integrate

People prescribed GLP-1 medications are more likely to start and stop than most people assume, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago. "Our study asked two questions that haven't been well answered until now: How many people with type 2 diabetes taking GLP-1 medications actually stop using them? And how many restart them?" said Dr Sainikhil Sontha, a research associate at Boston University School of Public Health in Bost

Metabolic and bariatric surgery (MBS) for teens with severe obesity is cost-effective over ten years, according to an analysis from Ann & Robert H Lurie Children's Hospital of Chicago, IL. While long-term clinical benefits of weight-loss surgery for eligible teens have been well established, and it is recommended by the American Academy of Pediatrics, insurance coverage has been limited and few teens can take advantage of the surgery. This study strengthens the case for insur